A lung cancer molecular prognostic test ready for prime time
Lancet
.
2012 Mar 3;379(9818):785-7.
doi: 10.1016/S0140-6736(12)60154-8.
Authors
Yang Xie
1
,
John D Minna
Affiliation
1
Department of Clinical Sciences, University of Texas, Southwestern Medical Center, TX 75390-8593, USA.
PMID:
22386017
PMCID:
PMC3382084
DOI:
10.1016/S0140-6736(12)60154-8
No abstract available
Publication types
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung / mortality*
Female
Humans
Lung Neoplasms / mortality*
Male
Polymerase Chain Reaction*
Grants and funding
P50 CA070907/CA/NCI NIH HHS/United States